Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00376909 · ClinicalTrials.gov registry record · Phase 2
A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women
A Phase 2 study of Breast Cancer and Colorectal Cancer, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,729
- Enrollment target
- 2
- Study locations
NCT00376909: Completed Phase 2 study of Breast Cancer and Colorectal Cancer, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00376909 is a Phase 2 study of Breast Cancer and Colorectal Cancer that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2,729 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00376909, a Phase 2 study of Breast Cancer and Colorectal Cancer, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,729 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Studying the barriers that prevent minority and low-income women from undergoing cancer screening, and offering encouragement to them over the telephone, may help improve cancer screening rates. PURPOSE: This randomized phase II trial is studying how well a telephone-based Prevention Care Manager increases screening rates for breast cancer, cervical cancer, and colorectal cancer in minority and low-income women.
Conditions Studied
Interventions
- OTHER educational intervention
- OTHER study of socioeconomic and demographic variables
Study Locations (2)
New Hampshire
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center - Lebanon
New York
- Clinical Directors Network, Incorporated - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,729 participants |
| Start Date | 2001-11 |
| Phase | Phase 2 |
What the finished NCT00376909 record still lists
NCT00376909 is an interventional study that assigns participants to a tested intervention. Its 2,729 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which educational intervention is the first listed.
NCT00376909 reports a single indexed study location in New Hampshire, New York.
Frequently Asked Questions
What is clinical trial NCT00376909 about?
NCT00376909 is a clinical study titled "A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women". RATIONALE: Studying the barriers that prevent minority and low-income women from undergoing cancer screening, and offering encouragement to them over the telephone, may help improve cancer screening rates. PURPOSE: This randomized phase II trial is studying how well a telephone-based Prevention Car...
What is the current status of trial NCT00376909?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,729 participants. The study started on 2001-11.
What conditions does trial NCT00376909 study?
This clinical trial studies the following conditions: Breast Cancer, Colorectal Cancer, Cervical Cancer.
What interventions are being tested in trial NCT00376909?
The interventions under investigation include: educational intervention (OTHER), study of socioeconomic and demographic variables (OTHER).
Who is sponsoring clinical trial NCT00376909?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00376909 being conducted?
This trial has 2 study locations across New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00376909's enrollment target sits among peer trials
2,729 52nd of 1224 higher than 1,173 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RECRUITING · Phase 2
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RECRUITING · Phase 2
-
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
RECRUITING · Phase 2
-
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
RECRUITING · Phase 2
-
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia